期刊
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
卷 41, 期 1, 页码 15-31出版社
SPRINGER
DOI: 10.1007/s11239-015-1314-3
关键词
Pharmacology; Mechanism of action; Anticoagulants; Warfarin; Heparins; Direct oral anticoagulants (DOAC)
资金
- Boehringer Ingelheim
- Daiichi Sankyo
- Janssen Pharmaceuticals
Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires not only an in-depth knowledge of their pharmacologic properties but also a comprehensive approach to patient management and education. This paper will summarize the key pharmacologic properties of the anticoagulant agents used in the treatment of patients with VTE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据